Atlas Trials

MAX-10181 Given Orally to Patients With Advanced Solid Tumor

Clinical trial NCT04122339 · UNKNOWN

Trial details

NCT number
NCT04122339
Sponsor
Maxinovel Pty., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2020-02-11
Primary completion
2022-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.